The burden of sleep disordered breathing in children with sickle cell disease. Issue 12 (25th August 2021)

• Record Type: Journal Article
• Authors: Liguoro, Ilaria; Arigliani, Michele; Tan, Hui‐Leng; Gupta, Atul
• Is Part Of: Pediatric pulmonology. Volume 56:Issue 12(2021)
• Page Start: 3607
• Page End: 3633
• Publication Date: 2021-08-25
• Subjects: children -- nocturnal oxygen desaturation -- sickle cell disease -- sleep apnea -- sleep disordered breathing; Pediatric respiratory diseases -- Periodicals; Pediatrics -- Periodicals; 618.922
• DOI: 10.1002/ppul.25632
• Languages: English
• ISSNs: 8755-6863

Abstract

Abstract: Children with sickle cell disease (SCD) have an increased risk of sleep disordered breathing (SDB) compared with the general pediatric population. There has been a growing research interest on this field in recent years, yet many questions regarding risk factors and clinical implications of SDB remain unclear. The aim of this review is to provide a concise narrative and systematic synthesis of the available evidence on the epidemiology, clinical presentation, complications, and management, of SDB in children with SCD. An electronic search was conducted on studies published from the 1st of January 2000 to the 31st of December 2020 in PubMed/Medline, Scopus, and Cochrane databases. All studies focusing on SDB in children with SCD aged from 0 to 20 years were included. Studies were eligible for inclusion if available in the English language. A quantitative synthesis of the included studies was performed. Only studies focusing on specific treatment outcomes were included in a meta‐analytic process. A total of 190 papers were initially identified. After screening the title and abstract, 112 articles were evaluated for eligibility. At the end of the selection process, 62 studies were included in the analysis. Sleep disordered breathing is associated with worse neurological, neurocognitive, and cardiological outcomes, whereas the association with frequency or severity of vaso‐occlusive pain events and acute chest syndrome was not clarified. Therapeutic interventions like adenotonsillectomy or oxygen supplementation may result in a significant increase in mean nocturnal oxygen saturation but effective clinical implications remain still unclear.